Clinical Trials Browser

Approved for marketing × OTHER × 3-Iodobenzylguanidine × Clear all

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Approved for marketing

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence